Shire tops flat European shares on bid hopes
LONDON, June 20
LONDON, June 20 (Reuters) - A rally in drugmaker Shire helped European bourses hold onto recent gains on Friday on news the British drugs maker had been the object of a takeover bid from U.S. rival AbbVie.
Shares in Shire rose 13 percent after AbbVie confirmed it had made a bid approach for the British group, which was rejected by Shire's board. It said talks were no longer ongoing.
"I'd probably take some profit there and then go back in," said Mike Reuter, a broker at Tradition. "The stock won't crash. It's an M&A candidate and I think there will be an offer, eventually."
Shire's stock added 0.9 points to the pan-European FTSEurofirst 300, which was up 1.1 points, or 0.1 percent at 1,396.53 points at 0711 GMT.
The index, which hit a 6-1/2 year high on Thursday, was on track for its tenth consecutive weekly gain, extending its longest winning run since August 2012. (Reporting By Francesco Canepa; editing by Blaise Robinson)
- Tesla says in talks with BMW over car batteries, parts
- Exclusive: China ready to cut rates again on fears of deflation - sources
- Actor Dwight Henry eyed in New Orleans killing after arrest for theft
- China building South China Sea island big enough for airstrip: report
- Suicide bomber kills 45 at volleyball match in Afghanistan
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video